Vitamin D3 Oral Dissolvable Film for Diverse Applications

Publication ID: 24-11857557_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Vitamin D3 Oral Dissolvable Film for Diverse Applications,” Published Technical Disclosure No. 24-11857557_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857557_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,557.

Summary of the Inventive Concept

The present inventive concept leverages the core technology of oral dissolvable films containing vitamin D3 to address various unmet needs in industries beyond human health, including livestock, agriculture, aquaculture, and pet care.

Background and Problem Solved

The original patent focused on delivering vitamin D3 to human subjects. However, the limitations of this approach are that it does not address the needs of other industries where vitamin D3 supplementation is crucial. The new inventive concept solves this problem by applying the oral dissolvable film technology to these underserved areas, providing a convenient and effective means of vitamin D supplementation.

Detailed Description of the Inventive Concept

The inventive concept involves the use of oral dissolvable films containing vitamin D3 in various applications. In livestock, the film is administered to prevent vitamin D deficiency and improve overall health. In agriculture, the film is applied to soil or plants to promote healthy plant growth and increase crop yields. In aquaculture, the film is added to aquarium water to promote healthy aquatic life and prevent vitamin D deficiency in aquatic organisms. In pet care, the film is administered to pets to provide essential vitamins and minerals. The oral dissolvable film technology offers a unique advantage in these industries due to its ease of use, convenience, and ability to provide targeted supplementation.

Novelty and Inventive Step

The new claims are novel and non-obvious compared to the original patent as they apply the oral dissolvable film technology to entirely new industries and use cases. The inventive step lies in recognizing the potential of the technology beyond human health and developing innovative applications that address specific needs in these industries.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include different formulations of the oral dissolvable film, varying concentrations of vitamin D3, or the use of different polymers or excipients. Additionally, the film could be adapted for use in other industries, such as veterinary medicine or environmental remediation.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the livestock, agriculture, aquaculture, and pet care industries, where vitamin D supplementation is a growing need. The market for vitamin D supplements is expected to continue growing, and the oral dissolvable film technology offers a unique value proposition in these industries. The potential applications are vast, and the inventive concept could lead to the development of new products and services that improve health and productivity in these industries.

Field of Art

Pharmaceutical formulation and drug delivery systems, specifically oral dissolvable film (ODF) technology with focus on vitamin and nutritional supplements

Person of Ordinary Skill (PHOSITA) Profile

A pharmaceutical scientist or formulation engineer with expertise in drug delivery systems, polymer chemistry, and nutritional supplementation, holding at least a master's degree with 3-5 years of experience in developing oral dosage forms

Obviousness Rationale

A PHOSITA would recognize that the core ODF technology for vitamin D3 delivery can be readily extended to different application domains by leveraging the fundamental film composition and delivery mechanism. The source patent establishes a robust platform technology for vitamin D3 supplementation, which naturally suggests exploring alternative delivery contexts beyond human health. The PTD's variations represent predictable extensions of the original technological framework using standard formulation and application techniques.

Obvious Combinations & Variations

Source Patent Element
Oral dissolvable film containing vitamin D3 for human health supplementation
PTD Variation
Applying the same ODF technology to livestock health management
Obviousness Reasoning
A PHOSITA would recognize that nutritional deficiency is a common challenge across biological systems, and the ODF delivery mechanism is adaptable to different species using known scaling and formulation techniques
Source Patent Element
Polymer-based film using sodium carboxymethyl cellulose and polyvinylpyrrolidone as key components
PTD Variation
Modifying film composition for agricultural and aquaculture applications
Obviousness Reasoning
The fundamental polymer chemistry is transferable across different use cases, with predictable modifications to address specific environmental or biological requirements
Source Patent Element
Enteral delivery method for vitamin D3 supplementation
PTD Variation
Expanding delivery methods to include soil application, aquarium water integration, and animal nutrition
Obviousness Reasoning
A PHOSITA would understand that vitamin D3 absorption mechanisms are fundamentally similar across biological systems, making cross-domain application a logical and predictable innovation
Source Patent Element
Method of preventing vitamin D deficiency through oral film administration
PTD Variation
Applying the supplementation strategy to diverse populations including livestock, plants, aquatic organisms, and pets
Obviousness Reasoning
The underlying therapeutic goal of addressing nutritional deficiency is consistent across different biological contexts, making the technological transfer obvious to a skilled practitioner
Source Patent Element
Oral film containing water, polymers, and active pharmaceutical ingredient
PTD Variation
Developing industry-specific film formulations with tailored polymer ratios and delivery mechanisms
Obviousness Reasoning
Polymer science and drug delivery principles allow predictable modifications to film composition based on specific application requirements, representing a standard engineering approach
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857557 and the published technical disclosure, a person having ordinary skill in the art would find the claimed variations in vitamin D3 oral dissolvable film applications to be obvious and lacking inventive step. The fundamental ODF technology provides a predictable platform for extending vitamin supplementation across diverse biological and industrial contexts, rendering subsequent claims obvious through standard formulation and application techniques.

Original Patent Information

Patent NumberUS 11,857,557
TitleOral dissolvable film containing vitamin D3